More SEC Filings
View Older Stories View Newer Stories-
Form SF-3 GS MORTGAGE SECURITIES
-
Form 4 CITY HOLDING CO For: Mar 26 Filed by: DERITO JOHN A
-
Form 4 Cyclerion Therapeutics, For: Mar 25 Filed by: Higgins Michael J
-
Form DEFA14A BlackRock, Inc.
-
Form 4 CITY HOLDING CO For: Mar 26 Filed by: BUMGARNER DAVID L
-
Form 10-K Kodiak Sciences Inc. For: Dec 31
-
Form POS AM Mobilicom Ltd
-
Form 8-K LENDWAY, INC. For: Mar 24
-
Form 4 KOHLS Corp For: Mar 25 Filed by: Raymond Christie
-
Form DEFA14A NEWELL BRANDS INC.
-
Form 10-K Inhibikase Therapeutics, For: Dec 31
-
Form 10-K Bicara Therapeutics Inc. For: Dec 31
-
Form 424B2 UBS AG
-
Form S-8 Camp4 Therapeutics Corp
-
Form 8-K INDIVIOR PLC For: Mar 27
-
Form 485BPOS GOLDMAN SACHS TRUST
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 425 Inception Growth Acquisi Filed by: Inception Growth Acquisition Ltd
-
Form 4 ACCO BRANDS Corp For: Mar 26 Filed by: Tedford Thomas W
-
Form DEF 14A UDR, Inc. For: Mar 27
-
Form 10-K FOOT LOCKER, INC. For: Feb 01
-
Form D BG Co-Investment 2024,
-
Form 8-K CAL-MAINE FOODS INC For: Mar 25
-
Form 144 Nu Holdings Ltd. Filed by: Duggal Jagpreet Singh
-
Form 424B2 UBS AG
-
Form DEF 14A Eos Energy Enterprises, For: May 15
-
Form 3 FTAI Infrastructure Inc. For: Mar 27 Filed by: Fletcher Carl Russell IV
-
Form 424B2 UBS AG
-
Form 4 Concentrix Corp For: Mar 25 Filed by: Hayley Kathryn
-
Form ARS Hamilton Insurance Group For: Dec 31
-
Form 424B2 UBS AG
-
Form 10-K NEXGEL, INC. For: Dec 31
-
Form 10-K FB Bancorp, Inc. /MD/ For: Dec 31
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 4 KOHLS Corp For: Mar 25 Filed by: Mc Feeney Siobhan
-
Form 424B2 UBS AG
-
Form 424B5 VICI Properties L.P.
-
Form DEFA14A PEABODY ENERGY CORP
-
Form S-8 POS Walt Disney Co
-
Form 24F-2NT U.S. Monthly Income Fund For: Dec 31
-
Form ATS-N/UA UBS SECURITIES LLC
-
Form X-17A-5 MANOR PRIVATE CAPITAL, For: Dec 31
-
Form 8-K INFINITY NATURAL RESOURC For: Mar 27
-
Form D Aeroblox Inc.
-
Form 6-K BANK OF CHILE For: Mar 27
-
Form S-8 ACUREN CORP
-
Form 8-K KULR Technology Group, For: Mar 27
-
Form S-1/A Silexion Therapeutics


